Neurogene: Inducement grants under Nasdaq listing rule 5635(c)(4)
Neurogene Inc. announced inducement grants under Nasdaq Listing Rule 5635(c)(4).
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.
News Feed
3 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
Neurogene Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Neurogene Inc. NASDAQ:NGNE
Neurogene grants 8,340 stock options to new employees
Neurogene Inc. granted non-qualified stock options to purchase an aggregate of 8,340 shares of common stock to five new employees under its 2025 Inducement Plan, on October 5, 2026.